MPH.V Stock - Medicure Inc.
Unlock GoAI Insights for MPH.V
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $21.91M | $21.69M | $23.07M | $21.74M | $11.61M |
| Gross Profit | $13.09M | $13.99M | $16.07M | $12.71M | $5.13M |
| Gross Margin | 59.7% | 64.5% | 69.7% | 58.5% | 44.2% |
| Operating Income | $-2,737,000 | $-854,000 | $1.31M | $-574,000 | $-7,287,000 |
| Net Income | $-1,039,000 | $-922,000 | $1.36M | $-727,000 | $-6,845,000 |
| Net Margin | -4.7% | -4.3% | 5.9% | -3.3% | -59.0% |
| EPS | $-0.10 | $-0.09 | $0.13 | $-0.07 | $-0.64 |
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers ReDS, a non-invasive medical device that offers measurement of lung fluid for the management of congestive heart failure. Further, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail pharmacies, as well as online. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.
Visit WebsiteEarnings History & Surprises
MPH.VEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 19, 2026 | — | — | — | — |
Q4 2025 | Nov 19, 2025 | — | $-0.13 | — | — |
Q3 2025 | Aug 20, 2025 | — | $-0.08 | — | — |
Q2 2025 | Apr 28, 2025 | — | $-0.07 | — | — |
Q2 2025 | Apr 22, 2025 | — | $-0.05 | — | — |
Q4 2024 | Nov 19, 2024 | — | $0.07 | — | — |
Q3 2024 | Aug 14, 2024 | — | $-0.12 | — | — |
Q2 2024 | May 28, 2024 | — | $0.00 | — | — |
Q2 2024 | Apr 8, 2024 | — | $-0.15 | — | — |
Q4 2023 | Nov 22, 2023 | — | $0.01 | — | — |
Q3 2023 | Jul 28, 2023 | — | $0.02 | — | — |
Q2 2023 | May 26, 2023 | — | $0.03 | — | — |
Q2 2023 | Apr 10, 2023 | — | $0.04 | — | — |
Q4 2022 | Nov 24, 2022 | — | $0.11 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.07 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.05 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.19 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.09 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.06 | — | — |
Q2 2021 | Apr 20, 2021 | $-0.04 | $-0.42 | -961.6% | ✗ MISS |
Latest News
Frequently Asked Questions about MPH.V
What is MPH.V's current stock price?
What is the analyst price target for MPH.V?
What sector is Medicure Inc. in?
What is MPH.V's market cap?
Does MPH.V pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to MPH.V for comparison